Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesReview: inhaled anticholinergics increase risk of major cardiovascular events in COPD
Evidence-Based Medicine, 05/08/09
Singh S - Inhaled anticholinergics increased risk of the composite end point, myocardial infarction, and cardiovascular death, but not stroke or all-cause death. Inhaled anticholinergics increased risk of the composite end point in the 5 long-term trials but not in the 12 short-term trials. This review concludes that in patients with chronic obstructive pulmonary disease, long-term use of inhaled anticholinergics increases risk of major cardiovascular events.
Related Articles
Bone mineral density and fractures in older men with chronic obstructive pulmonary disease or asthma
Osteoporosis International, 10/13/09
Relevance Score: 92%
Interaction in COPD experiment (ICE): A hazardous combination of cigarette smoking and bronchodilation in chronic obstructive pulmonary disease
Medical Hypotheses, 10/08/09
Relevance Score: 91%
Molecular Characterization of Chronic Obstructive Pulmonary Disease-Related Non-Small Cell Lung Cancer Through Aberrant Methylation and Alterations of EGFR Signaling
Annals of Surgical Oncology, 10/23/09
Relevance Score: 90%
Tiotropium HandiHaler in the treatment of COPD: A safety review
International Journal of COPD, 10/29/09
Relevance Score: 89%
Living with advanced chronic obstructive pulmonary disease: patients concerns regarding death and dying
Palliative Medicine, 10/16/09
Relevance Score: 89%
Today in COPD...keeping you current
Receive free subspecialty "5-minute updates" via email
Low Erythropoietin Plasma Levels during Exacerbations of COPD
Respiration, 12/16/09
Measuring exacerbations in obstructive lung disease
Pharmacoepidemiology and Drug Safety, 12/16/09
Spatial Heterogeneity of Lung Perfusion Assessed with 13N PET as a Vascular Biomarker in Chronic Obstructive Pulmonary Disease
The Journal of Nuclear Medicine, 12/16/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Oral Immunotherapy with inactivated NTHi reduces severity of acute exacerbations in severe COPD
Chest, 12/16/09
Use of oseltamivir in children
Canadian Family Physician, 12/16/09
Measuring exacerbations in obstructive lung disease
Pharmacoepidemiology and Drug Safety, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor